Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.72%
#2 Ocean Protocol Ocean Protocol +18.39%
#3 Audiera Audiera +12.88%
#4 Cysic Cysic +12.35%
#5 KUB Coin KUB Coin +12.19%
#6 Geodnet Geodnet +11.47%
#7 Perle Perle +8.62%
#8 Wiki Cat Wiki Cat +8.49%
#9 Quack AI Quack AI +8.27%
#10 DexNet DexNet +7.78%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Настройки
Язык
Pусский
Валюта
USD
Тема
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Ранг среди акций #32247
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Цена акции
$0.8013
Последняя синхронизация: 2026-08-05
Рыночная капитализация
$10.62M
Изменение (1 день)
0.97%
Изменение (1 год)
-37.88%
Страна
US
Торговля Hoth Therapeutics, Inc. (HOTH)

Категория

Healthcare
Коэффициент P/B для Hoth Therapeutics, Inc. (HOTH)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Hoth Therapeutics, Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Hoth Therapeutics, Inc. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR